Home
Videos
Podcasts
Groups
Reviews
Blogs
Q&A Forum
News
Publications
Events
Jobs
Q&A Forum
Q: Biosimilar Products
What are issues in conducting bioequivalence studies with bio-similar products
1 answers | Asked by Manoj Karwa | 1289 days
What are issues in conducting bioequivalence studies with bio-similar products
1 answers | Asked by Manoj Karwa | 1289 days
Q: Food Testing
Why is there renewed concern about melamine adulteration in food and feed?
0 answers | Asked by Manoj Karwa | 1289 days
Why is there renewed concern about melamine adulteration in food and feed?
0 answers | Asked by Manoj Karwa | 1289 days
Q: Preclinical
Is abuse liability assesment at preclinical stage mandatory for CNS drugs
0 answers | Asked by Manoj Karwa | 1289 days
Is abuse liability assesment at preclinical stage mandatory for CNS drugs
0 answers | Asked by Manoj Karwa | 1289 days
Q: Food Testing
What are different method available for testing GMO (genetically modified organism).
0 answers | Asked by Manoj Karwa | 1289 days
What are different method available for testing GMO (genetically modified organism).
0 answers | Asked by Manoj Karwa | 1289 days
Q: Biotechnology
How PCR (polymerase chain reaction) has given a renewed concept to diagnostic market.
0 answers | Asked by Manoj Karwa | 1289 days
How PCR (polymerase chain reaction) has given a renewed concept to diagnostic market.
0 answers | Asked by Manoj Karwa | 1289 days
Q: Networking
Is networking website or forum really helping people in getting technical solution of their problems
5 answers | Asked by Manoj Karwa | 1289 days
Is networking website or forum really helping people in getting technical solution of their problems
5 answers | Asked by Manoj Karwa | 1289 days
Q: Clinical Trial
Which region in the globe is the best for clinical research in term of providing the quality data in cost effective manner
0 answers | Asked by Manoj Karwa | 1289 days
Which region in the globe is the best for clinical research in term of providing the quality data in cost effective manner
0 answers | Asked by Manoj Karwa | 1289 days
Q: Bioequivalence
What data set required for considering a molecule in biowaiver category
0 answers | Asked by Manoj Karwa | 1289 days
What data set required for considering a molecule in biowaiver category
0 answers | Asked by Manoj Karwa | 1289 days
Q: Clinical Research
What are the free online tool or resources available for clinical research professioans.
1 answers | Asked by Manoj Karwa | 1289 days
What are the free online tool or resources available for clinical research professioans.
1 answers | Asked by Manoj Karwa | 1289 days
Q: Clinical Trial
How SMO function is different from CRO.
0 answers | Asked by Manoj Karwa | 1289 days
How SMO function is different from CRO.
0 answers | Asked by Manoj Karwa | 1289 days
Q: Bioequivalence
How a bioequivalence study in cancer patient can be designed by taking consideration of different stages and type of cancer with managing his current treatment.
0 answers | Asked by Manoj Karwa | 1289 days
How a bioequivalence study in cancer patient can be designed by taking consideration of different stages and type of cancer with managing his current treatment.
0 answers | Asked by Manoj Karwa | 1289 days
Q: Bioequivalence
How to choose a RLD or Reference Drug for a FDC (Fixed Dose Combination) in bioequivalence study if FDC is not available in regulated market?
0 answers | Asked by Manoj Karwa | 1289 days
How to choose a RLD or Reference Drug for a FDC (Fixed Dose Combination) in bioequivalence study if FDC is not available in regulated market?
0 answers | Asked by Manoj Karwa | 1289 days
Q: Personalised medicine, ethical or marketing?
Nowadays, we are living in an era where looking for the “bad” guy gene is becoming the rule in medicine. If we profile the bad guy-gene, we can block/tackle/inhibit its effects. Several new drugs approved by FDA, EMEA fall into this kind of drugs. However, as nature already showed previously, medicine is a holistic science rather than a...[more]
0 answers | Asked by Victor JUAREZ PEREZ | 1289 days
Nowadays, we are living in an era where looking for the “bad” guy gene is becoming the rule in medicine. If we profile the bad guy-gene, we can block/tackle/inhibit its effects. Several new drugs approved by FDA, EMEA fall into this kind of drugs. However, as nature already showed previously, medicine is a holistic science rather than a...[more]
0 answers | Asked by Victor JUAREZ PEREZ | 1289 days
Q: Scientists Decode Set of Cancer Genes
For the first time, researchers have decoded all the genes of a person with cancer and found a set of mutations that might have caused the disease or aided its progression. http://www.nytimes.com/2008/11/06/health/research/06cancer.html?_r=1&hp&oref=slogin Your thoughts?
1 answers | Asked by Michael Downey | 1289 days
For the first time, researchers have decoded all the genes of a person with cancer and found a set of mutations that might have caused the disease or aided its progression. http://www.nytimes.com/2008/11/06/health/research/06cancer.html?_r=1&hp&oref=slogin Your thoughts?
1 answers | Asked by Michael Downey | 1289 days
Q: What do you know about blood pressure regulation?
Did You Know that Hydrogen Sulfide is a Key Pressure Regulator? Cells inside the blood vessels of mice -- and probably humans -- naturally make the gas hydrogen sulfide, which helps regulate blood pressure by relaxing blood vessels, according to an international team of scientists. "Now that we know hydrogen sulfide's role in regulating blood...[more]
0 answers | Asked by Richard Persen | 1290 days
Did You Know that Hydrogen Sulfide is a Key Pressure Regulator? Cells inside the blood vessels of mice -- and probably humans -- naturally make the gas hydrogen sulfide, which helps regulate blood pressure by relaxing blood vessels, according to an international team of scientists. "Now that we know hydrogen sulfide's role in regulating blood...[more]
0 answers | Asked by Richard Persen | 1290 days
Q: Public access to genomic data
In 2004, Ekhard Wimmer and Jeronimo Cello produced de novo virulent and infectious poliovirus virions using genomic sequence data from internet databases (e.g. Genbank). The media had a field day, but the scientific community, for the most part, ignored their efforts. In fact, many "experts" even suggested that 'someone with average skill could...[more]
3 answers | Asked by Jason Garner | 1292 days
In 2004, Ekhard Wimmer and Jeronimo Cello produced de novo virulent and infectious poliovirus virions using genomic sequence data from internet databases (e.g. Genbank). The media had a field day, but the scientific community, for the most part, ignored their efforts. In fact, many "experts" even suggested that 'someone with average skill could...[more]
3 answers | Asked by Jason Garner | 1292 days
Q: Biotech Industry Affected by Market Crash?
With the performance of the NASDAQ biotech index so far this year, you will see that the biotech sector has outperformed the market (with specific cases such as Celgene & Regeneron). Thanks to some recent breakthroughs within genomics and proteomics, it is probably likely that we’ll see growth in the molecular diagnostics market. Do you t...[more]
0 answers | Asked by Jamie Cruikshank | 1295 days
With the performance of the NASDAQ biotech index so far this year, you will see that the biotech sector has outperformed the market (with specific cases such as Celgene & Regeneron). Thanks to some recent breakthroughs within genomics and proteomics, it is probably likely that we’ll see growth in the molecular diagnostics market. Do you t...[more]
0 answers | Asked by Jamie Cruikshank | 1295 days
Q: Autism Genes
Is anyone out there doing research on genes thought to be associated with autism spectrum disorders? Particularly genes associated with glutamate synapse pathways and serotonin transport??
2 answers | Asked by Jamie Cruikshank | 1295 days
Is anyone out there doing research on genes thought to be associated with autism spectrum disorders? Particularly genes associated with glutamate synapse pathways and serotonin transport??
2 answers | Asked by Jamie Cruikshank | 1295 days
Q: What do you know about "personalized medicine?"
It isn't what it sounds like. Explore this new site to see breakthrough thinking in action: www.ageofpersonalizedmedicine.org
1 answers | Asked by Richard Persen | 1296 days
It isn't what it sounds like. Explore this new site to see breakthrough thinking in action: www.ageofpersonalizedmedicine.org
1 answers | Asked by Richard Persen | 1296 days
Q: Patentability Issues in Biotech and Pharma
Last year the Supreme Court created the "KSR" decision regarding standards for patentability within Biotech and Pharma. Many researchers and patent attorneys argued that the KSR decision did more to clarify what a test WAS NOT, rather than what it ACTUALLY WAS. The Biotechnology Industry Organization (BIO)and the Pharmaceutical Research and Manu...[more]
0 answers | Asked by Jamie Cruikshank | 1296 days
Last year the Supreme Court created the "KSR" decision regarding standards for patentability within Biotech and Pharma. Many researchers and patent attorneys argued that the KSR decision did more to clarify what a test WAS NOT, rather than what it ACTUALLY WAS. The Biotechnology Industry Organization (BIO)and the Pharmaceutical Research and Manu...[more]
0 answers | Asked by Jamie Cruikshank | 1296 days
Q: Emissions Cap and Trade System for CO2?
In 1994 and 1999, the federal government implemented cap-and-trade programs for Sulfur dioxide and NOx (Ozone), respectively. While hotspots for each still exist, the total emissions of both have been significantly reduced. Now, public officials at all levels of government are proposing a similar system for CO2 emissions. Both presidential candi...[more]
0 answers | Asked by Michael Downey | 1296 days
In 1994 and 1999, the federal government implemented cap-and-trade programs for Sulfur dioxide and NOx (Ozone), respectively. While hotspots for each still exist, the total emissions of both have been significantly reduced. Now, public officials at all levels of government are proposing a similar system for CO2 emissions. Both presidential candi...[more]
0 answers | Asked by Michael Downey | 1296 days
Q: Most Promising Source of Alternative Energy?
As nations across the world begin (or continue) transitioning to alternative energies, it is interesting to think which will be the most promising. Of course, no current technology is flawless, but we must weigh the benefits and drawbacks of each. Each technology produces clean, renewable energy and could be instrumental in reducing or reversing ...[more]
1 answers | Asked by Michael Downey | 1297 days
As nations across the world begin (or continue) transitioning to alternative energies, it is interesting to think which will be the most promising. Of course, no current technology is flawless, but we must weigh the benefits and drawbacks of each. Each technology produces clean, renewable energy and could be instrumental in reducing or reversing ...[more]
1 answers | Asked by Michael Downey | 1297 days
Q: Alternative Energy and the Balance of World Power
As the world population continues to grow, and nations like China and India continue to industrialize, global energy requirements will continue to grow exponentially. However, unless cost-effective and large-scale alternative energy projects are installed and implemented, the process of global climate change will continue and will likely have detr...[more]
1 answers | Asked by Michael Downey | 1297 days
As the world population continues to grow, and nations like China and India continue to industrialize, global energy requirements will continue to grow exponentially. However, unless cost-effective and large-scale alternative energy projects are installed and implemented, the process of global climate change will continue and will likely have detr...[more]
1 answers | Asked by Michael Downey | 1297 days
Q: Joint Replacements for Baby Boomers
How many opportunities are out there for baby boomer joint replacement therapy? Take a look: http://www.allbusiness.com/health-care/medical-practice-orthopedics/5423349-1.html
0 answers | Asked by Richard Persen | 1297 days
How many opportunities are out there for baby boomer joint replacement therapy? Take a look: http://www.allbusiness.com/health-care/medical-practice-orthopedics/5423349-1.html
0 answers | Asked by Richard Persen | 1297 days
Q: Big Bang
If the Hubble telescope is capable of seeing galaxies out 12+ billion light years away, and the age of the universe is estimated to be just beyond 12 or 13 billion years, then we must be approaching the point of seeing the big bang or the birth of our universe. The new space telescope, the James Webb telescope, will be able to see beyond the Hubbl...[more]
11 answers | Asked by Don Cruikshank | 1297 days
If the Hubble telescope is capable of seeing galaxies out 12+ billion light years away, and the age of the universe is estimated to be just beyond 12 or 13 billion years, then we must be approaching the point of seeing the big bang or the birth of our universe. The new space telescope, the James Webb telescope, will be able to see beyond the Hubbl...[more]
11 answers | Asked by Don Cruikshank | 1297 days
